Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9659175.
- Also identified by PMC identifier 1727106.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
It is believed that severe portal hypertensive gastropathy probably accounts for most non-variceal bleeding episodes in patients with cirrhosis. Gastric antral vascular ectasia (GAVE) also occurs in these patients. It is not clear whether it is a variant of portal hypertensive gastropathy or a distinct condition. A patient, a 66 year od woman, with cirrhosis initially diagnosed as having portal hypertensive gastropathy and subsequently classified as GAVE is described. She required transfusion with a total of 130 units of packed red cells for gastrointestinal blood loss. The bleeding did not respond to portal decompression with TIPS or beta blockers. Following treatment with oral tranexamic acid she has not required further blood transfusion over a period of 30 months. Tranexamic acid may be a useful treatment for refractory bleeding due to gastric antral vascular ectasia in patients with cirrhosis.
Medical subject headings
- Antifibrinolytic Agents
- Gastrointestinal Hemorrhage
- Liver Cirrhosis
- Stomach Diseases
- Tranexamic Acid
- Vascular Diseases